Kezar Life Sciences, Inc. KZR
Set alert
7.29 USD 0.00 0.00%
At close · May 11
7.37 +0.08 +1.10%
After hours · May 11, 4:00 PM ET
7.29 Day range 7.29
52-week range unavailable
- YTD
- +15.90%
- 1 year
- +72.75%
- Open
- 7.29
- Prev close
- 7.29
- Mkt cap
- 46.99M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 7.29
- High
- 7.29
- Forward P/E
- -0.62
- Beta
- 0.22
- Short ratio
- 0.93
- Inst. own
- 63.90%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 13, 2024
- 50-d avg
- 7.44
- 200-d avg
- 7.19
- 1y target
- 13.50
Analyst view
Consensus: buy
Buy
Price target (mean) 13.50 +85.2% upside
Now 7.29
- Target (low)
- 9.00
- Target (mean)
- 13.50
- Target (high)
- 18.00
Ratings (0m) 6 2 buy · 4 hold · 0 sell
- Strong buy0
- Buy2
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 6
- 3 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -2.76 | -2.78 – -2.74 | -3.58 | +23.0% | 0 | 0.0% | 2 |
| Next quarter | -2.79 | -2.79 – -2.79 | -3.00 | +7.0% | 0 | 0.0% | 1 |
| Current year | -2.11 | -2.11 – -2.11 | -13.19 | +84.0% | 0 | -100.0% | 1 |
| Next year | -9.29 | -15.00 – -3.51 | -2.11 | -340.1% | 0 | 0.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 19, 2024 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Dec 2, 2024 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Nov 14, 2024 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 18, 2024 | HC Wainwright & Co. | Reiterated | — | Neutral |
| Oct 14, 2024 | HC Wainwright & Co. | Reiterated | — | Neutral |
| Oct 2, 2024 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Aug 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 22, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 10, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 4, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 27, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 14, 2023 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 12, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 5, 2023 | JonesTrading | Downgrade | Buy | Hold |
| Sep 25, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 11, 2023 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| Aug 11, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 12, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 12, 2023 | Wells Fargo | Maintained | Overweight | Overweight |
| Mar 16, 2023 | William Blair | Downgrade | Outperform | Market Perform |
| Mar 16, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Jan 3, 2023 | Wells Fargo | Maintained | — | Overweight |
| Aug 12, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Jun 28, 2022 | Wells Fargo | Maintained | — | Overweight |
| May 13, 2022 | Wells Fargo | Maintained | — | Overweight |
| May 4, 2022 | Wells Fargo | Maintained | — | Overweight |
| Mar 18, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Dec 8, 2021 | Wells Fargo | Initiated | — | Overweight |
| Nov 16, 2021 | HC Wainwright & Co. | Maintained | — | Buy |